Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1374051
                    [Title] => New therapies provide optimism in chronic HCV
                    [Summary] => 
Chronic hepatitis C virus infection is currently responsible for more US deaths than HIV; is complicated to treat; is not vaccine preventable; and is a major driver of liver transplants, cirrhosis, chronic and end-stage liver disease, and liver cancer.

                    [DatePublished] => 2014-09-28 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 274225
                    [Title] => 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without  booster doses in children
                    [Summary] => The long-term immunogenicity and efficacy of hepatitis B (HBV) vaccination remain to the defined. We aimed to examine the long-term immunogenicity and efficacy of HBV vaccination with 3 different regimens over 18 years of follow-up. Methods: A total of 318 Chinese subjects receiving 3 different regimens of HBV vaccination (2-dose recombinant vs. 3-dose recombinant  vs. 3-dose plasma-derived vaccines) without receiving a booster dose were recruited.
                    [DatePublished] => 2005-04-17 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

REGIMENS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1374051
                    [Title] => New therapies provide optimism in chronic HCV
                    [Summary] => 
Chronic hepatitis C virus infection is currently responsible for more US deaths than HIV; is complicated to treat; is not vaccine preventable; and is a major driver of liver transplants, cirrhosis, chronic and end-stage liver disease, and liver cancer.

                    [DatePublished] => 2014-09-28 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 274225
                    [Title] => 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without  booster doses in children
                    [Summary] => The long-term immunogenicity and efficacy of hepatitis B (HBV) vaccination remain to the defined. We aimed to examine the long-term immunogenicity and efficacy of HBV vaccination with 3 different regimens over 18 years of follow-up. Methods: A total of 318 Chinese subjects receiving 3 different regimens of HBV vaccination (2-dose recombinant vs. 3-dose recombinant  vs. 3-dose plasma-derived vaccines) without receiving a booster dose were recruited.
                    [DatePublished] => 2005-04-17 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

New therapies provide optimism in chronic HCV

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | September 28, 2014 - 12:00am

Chronic hepatitis C virus infection is currently responsible for more US deaths than HIV; is complicated to treat; is not vaccine preventable; and is a major driver of liver transplants, cirrhosis, chronic and end-stage...

Opinion

18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | April 17, 2005 - 12:00am

The long-term immunogenicity and efficacy of hepatitis B (HBV) vaccination remain to the defined. We aimed to examine the long-term immunogenicity and efficacy of HBV vaccination with 3 different regimens over 18...

Opinion